Studies show high out-of pocket costs limit access to lifesaving specialty drugs
"Specialty drugs" have become important treatment options for many serious and chronic diseases, and in some conditions like cancer they represent the only chance for long-term survival. But, insurers increasingly require ...
Mar 28, 2016
0
7